Neurolutions, Inc.

Neurolutions develops the IpsiHand Upper Extremity Rehabilitation System, an FDA-cleared brain-computer interface (BCI) device for home-based motor recovery therapy in chronic stroke survivors. The non-invasive system comprises an EEG headset that captures motor intention signals from the unimpaired brain hemisphere, a powered wireless handpiece that moves the affected hand, and a tablet interface for guided treatment and progress tracking. Clinical data shows approximately 70% of trial participants improved arm and hand function, with an average 8.1-point improvement on the Fugl-Meyer Assessment within 12 weeks. IpsiHand enables patients to overcome recovery plateaus years or decades post-stroke through autonomous home therapy, with broad insurance coverage including Medicare and VA benefits.